TNK2 and breast cancer: Given the previous reported role of TNK2 in EGFR dynamics [17,19] and the potential impact of EGFR activation on migration and cytoskeleton remodelling [22,23], we hypothesised that the EGFR might be involved in the mechanism of action of TNK2 in breast cancer cells and hence be related to the observed morphological phenotype.